北京大学肿瘤医院

大众版专业版手机APP

返回

顶部

网站导航
当前位置:首页 >> 科研教育 >> 科学研究 >> 重点实验室 >> 科学研究及主要成果 > 正文

重点实验室

科学研究及主要成果

2011年主要论文

发表时间:2015-07-23

    1. Guo J, Si L, Kong Y, Flaherty KT, Xu X, Zhu Y, Corless CL, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lin X, Du N, Zhang X, Li J, Wang B, Qin S. Phase II, openlabel, singlearm trial of imatinib mesylate in patients with metastatic melanoma harboring cKit mutation or amplification. J Clin Oncol. 2011;29(21):29049. (IF=18.97)

    2. Xiaohan Yang, Wenhua Yu, Lei Shi, Luyang Sun, Jing Liang, Xia Yi, Qian Li, Yu Zhang, Fen Yang, Xiao Han, Di Zhang, Jie Yang, Zhi Yao, and Yongfeng Shang. HAT4, a Golgi Apparatus-Anchored B-Type Histone Acetyltransferase, Acetylates Free Histone H4 and Facilitates Chromatin Assembly. Molecular Cell. 2011 Oct;44:39-50. (IF=14.19)

    3. Ying Zhao, Yachen Wang, and Wei-Guo Zhu. Applications of post-translational modifications of FoxO family proteins in biological functions. Journal of Molecular Cell Biology. 2011;3:276-282. (IF=13.4)

    4. Xiangyu Liu, Donglai Wang, Ying Zhao, BoTu, Zhixing Zheng, Lina Wang, Haiying Wang, Wei Gu, Robert G. Roeder, and Wei-Guo Zhu. Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1). Proc Natl Acad Sci U S A. 2011 Feb;108(5):1925-1930. (IF=9.43)

    5. Lei Shi, Luyang Sun, Qian Li, Jing Liang, Wenhua Yu, Xia Yi, Xiaohan Yang, Yanyan Li, Xiao Han, Yu Zhang, Chenghao Xuan, Zhi Yao, and Yongfeng Shang. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci U S A. May 3, 2011;108(18):7541–7546. (IF=9.43)

    6. Qian Li, Lei Shi, Bin Gui, Wenhua Yu, Jiamu Wang, Di Zhang, Xiao Han, Zhi Yao, and Yongfeng Shang. Binding of the JmjC Demethylase JARID1B to LSD1/NuRD Suppresses Angiogenesis and Metastasis in Breast Cancer Cells by Repressing Chemokine CCL14. Cancer Research. 2011;71(21):6899-908. (IF=8.23)

    7. Shi Y, Chen J, Li Z, Zhang Z, Yu H, Sun K, Wang X, Song X, Wang Y, Zhen Y, Yang T, Lou K, Zhang Y, Zhang G, Hu Y, Ji J, Hui R. C10ORF97 is a novel tumorsuppressor gene of nonsmallcell lung cancer and a functional variant of this gene increases the risk of nonsmallcell lung cancer. Oncogene. 2011;30(39):410717. (IF=7.41)

    8. Kong Y, Si L, Zhu Y, Xu X, Corless CL, Flaherty KT, Li L, Li H, Sheng X, Cui C, Chi Z, Li S, Han M, Mao L, Lu A, Guo J. Largescale analysis of KIT aberrations in Chinese patients with melanoma. Clin Cancer Res. 2011;17(7):168491. (IF=7.34)

    9. Yuan Ruan, Ai-Ping Song, Hui Wang, Yun-Tao Xie, Ji-Yuan Han, Constantin Sajdik, Xin-Xia Tian,and Wei-Gang Fang. Genetic polymorphisms in AURKA and BRCA1 are associated with breast cancer susceptibility in a Chinese Han population. Journal of Pathology. 2011;225:535–543. (IF=7.27)

    10. Jing Yang, Ying Zhao, Ke Ma, Fen-Jun Jiang, Wenjuan Liao, Ping Zhang, Jingyi Zhou, Bo Tu, Lina Wang, Harm H. Kampinga, Zhiping Xie, and Wei-Guo Zhu. Deficiency of hepatocystin induces autophagy through an mTOR-dependent pathway. Autophagy. 2011 Jul;7(7):748-759. (IF=6.64)

    11. Yao L, Liu Y, Li Z, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. HER2 and response to anthracyclinebased neoadjuvant chemotherapy in breast cancer. Ann Oncol. 2011;22(6):132631. (IF=6.45)

    12. Zhang X, Yan Z, Zhang J, Gong L, Li W, Cui J, Liu Y, Gao Z, Li J, Shen L, Lu Y. Combination of hsamiR375 and hsamiR1425p as a predictor for recurrence risk in gastric cancer patients following surgical resection. Ann Oncol. 2011;22(10):225766. (IF=6.45)

    13. Wang HZ, Peng ZY, Wen XY, Rimmelé T, Bishop JV, Kellum JA. Nacetylcysteine is effective for prevention but not for treatment of folic acidinduced acute kidney injury in mice. Crit Care Med. 2011;39(11):248794. (IF=6.25)

    14. Tang L, Zhang XP, Sun YS, Shen L, Li J, Qi LP, Cui Y. Gastrointestinal stromal tumors treated with imatinib mesylate: apparent diffusion coefficient in the evaluation of therapy response in patients. Radiology. 2011;258(3):72938. (IF=6.07)

    15. Liu Y, Liao J, Xu Y, Chen W, Liu D, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xu X, Xie Y. A recurrent CHEK2 p.H371Y mutation is associated with breast cancer risk in Chinese women. Hum Mutat. 2011;32(9):10003. (IF=5.96)

    16. Zhang H, Zhang X, Sun Y, Liu J, Li W, Tian J. A weightedRV method to detect finescale functional connectivity during resting state. Neuroimage. 2011;54(4):288598. (IF=5.93)

    17. Chen J, Shi Y, Li Z, Yu H, Han Y, Wang X, Sun K, Yang T, Lou K, Song Y, Zhang Y, Zhen Y, Zhang G, Hu Y, Ji J, Hui R. A functional variant of IC53 correlates with the late onset of colorectal cancer. Mol Med. 2011;17(78):60718. (IF=5.91)

    18. Li WQ, Pan KF, Zhang Y, Dong CX, Zhang L, Ma JL, Zhou T, Li JY, You WC. RUNX3 methylation and expression associated with advanced precancerous gastric lesions in a Chinese population. Carcinogenesis. 2011;32(3):40610. (IF=5.40)

    19. Yanyan Li, Luyang Sun, Yu Zhang, Dandan Wang, Feng Wang, Jing Liang, Bin Gui, and Yongfeng Shang. The Histone Modifications Governing TFF1 Transcription Mediated by Estrogen Receptor. The Journal Of Biological Chemistry. April 22, 2011, 286(16):13925–13936. (IF=5.33)

    20. Luyang Sun, Lei Shi, Feng Wang, Peiwei Huangyang, Wenzhe Si, Jie Yang, Zhi Yao, and Yongfeng Shang. Substrate Phosphorylation and Feedback Regulation in JFK-promoted p53 Destabilization. J Biol Chem. February 11, 2011, 286(6, ):4226–4235. (IF=5.33)

    21. Kong R, Zhang L, Hu L, Peng Q, Han W, Du X, Ke Y. hALP, a novel transcriptional U three protein (tUTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF). J Biol Chem. 2011;286(9):713948. (IF=5.33)

    22. Zhong J, Liao J, Liu X, Wang P, Liu J, Hou W, Zhu B, Yao L, Wang J, Li J, Stark JM, Xie Y, Xu X. Protein phosphatase PP6 is required for homologydirected repair of DNA doublestrand breaks. Cell Cycle. 2011;10(9):14119. (IF=5.0)

    23. Zhao W, Han HB, Zhang ZQ. Suppression of lung cancer cell invasion and metastasis by connexin43 involves the secretion of follistatinlike 1 mediated via histone acetylation. Int J Biochem Cell Biol. 2011;43(10):145968. (IF=4.96)

    24. Mao L, Si L, Chi Z, Cui C, Sheng X, Li S, Tang B, Guo J. A randomised phase II trial of 1 month versus 1 year of adjuvant highdose interferon α2b in highrisk acral melanoma patients. Eur J Cancer. 2011;47(10):1498503. (IF=4.94)

    25. Shen LY, Chen KN. Exploration of target genes of HOXA13 in esophageal squamous cell carcinoma cell line. Cancer Lett. 2011;312(1):1823. (IF=4.86)

    26. Pang Z, Yao L, Zhang J, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Xie Y. RAD51C germline mutations in Chinese women with familial breast cancer. Breast Cancer Res Treat. 2011;129(3):101920. (IF=4.86)

    27. Yu Zhang, Xiaohan Yang, Bin Gui, Guojia Xie, Di Zhang, Yongfeng Shang, and Jing Liang. Corepressor Protein CDYL Functions as a Molecular Bridge between Polycomb Repressor Complex 2 and Repressive. J Biol Chem. 2011;286(49):42414-42425. (IF=4.77)

    28. Zeng HM, Pan KF, Zhang Y, Zhang L, Ma JL, Zhou T, Su HJ, Li WQ, Li JY, Gerhard M, Classen M, You WC. Genetic variants of tolllike receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2594602. (IF=4.12)

    29. Li Y, Hu X, Song Y, Lu Z, Ning T, Cai H, Ke Y. Identification of novel alternative splicing variants of interferon regulatory factor 3. Biochim Biophys Acta. 2011;1809(3):16675. (IF=4)

    30. Wu ZL, Song YQ, Shi YF, Zhu J. High nuclear expression of STAT3 is associated with unfavorable prognosis in diffuse large Bcell lymphoma. J Hematol Oncol. 2011;4(1):31. (IF=3.99)

    31. Gao Y, Su Y, Qu L, Xu S, Meng L, Cai SQ, Shou C. Mitochondrial apoptosis contributes to the anticancer effect of Smilax glabra Roxb. Toxicol Lett. 2011;207 (2):11220. (IF=3.58)

    32. Xing XF, Li H, Zhong XY, Zhang LH, Wang XH, Liu YQ, Jia SQ, Shi T, Niu ZJ, Peng Y, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Chen S, Ji JF. Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer. Histopathology. 2011;59(2):198206. (IF=3.57)

    33. Xie F, Ye L, Chen J, Wu N, Zhang Z, Yang Y, Zhang L, Jiang WG. The impact of Metastasis Suppressor1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance. J Transl Med. 2011;9:95. (IF=3.51)

    34. Li Y, Basang Z, Ding H, Lu Z, Ning T, Wei H, Cai H, Ke Y. Latexin expression is downregulated in human gastric carcinomas and exhibits tumor suppressor potential. BMC Cancer. 2011;11:121. (IF=3.15)

    35. Chi Z, Li S, Sheng X, Si L, Cui C, Han M, Guo J. Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: a study of 522 consecutive cases. BMC Cancer. 2011;11:85. (IF=3.15)

    36. Zhang XP, Wang ZL, Tang L, Sun YS, Cao K, Gao Y. Support vector machine model for diagnosis of lymph node metastasis in gastric cancer with multidetector computed tomography: a preliminary study. BMC Cancer. 2011;11:10. (IF=3.15)

    37. Gao J, Lu M, Yu JW, Li YY, Shen L. Thymidine Phosphorylase/β-tubulin III expressions predict the response in Chinese advanced gastric cancer patients receiving first-line capecitabine plus paclitaxel. BMC Cancer. 2011;11:177. (IF=3.01)